Identification of molecular glues of the SLP76/14-3-3 protein-protein interaction

The stabilisation of protein-protein interactions (PPIs) through molecular glues is a novel and promising approach in drug discovery. In stark contrast to research in protein-protein inhibition the field of stabilisation remains underdeveloped with comparatively few examples of small-molecule stabil...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:RSC medicinal chemistry Ročník 12; číslo 9; s. 1555 - 1564
Hlavní autoři: Soini, Lorenzo, Redhead, Martin, Westwood, Marta, Leysen, Seppe, Davis, Jeremy, Ottmann, Christian
Médium: Journal Article
Jazyk:angličtina
Vydáno: RSC 23.09.2021
Témata:
Chemistry
ISSN:2632-8682, 2632-8682
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract The stabilisation of protein-protein interactions (PPIs) through molecular glues is a novel and promising approach in drug discovery. In stark contrast to research in protein-protein inhibition the field of stabilisation remains underdeveloped with comparatively few examples of small-molecule stabilisers of PPIs reported to date. At the same time identifying molecular glues has received recent sustained interest, especially in the fields of targeted protein degradation and 14-3-3 PPIs. The hub-protein 14-3-3 has a broad interactome with more than 500 known protein partners which presents a great opportunity for therapeutic intervention. In this study we have developed an HTRF assay suitable for HTS of the 14-3-3/SLP76 PPI and have completed a proof of concept screen against a chemically diverse library of 20 K molecules. The adaptor protein SLP76 has been reported to interact with 14-3-3 proteins downstream of the TCR playing an important role in mediating its own proteasomal degradation. We believe that stabilisation of this PPI could be exploited to potentiate degradation of SLP76 and therefore inhibit TCR signalling. This would represent an interesting alternative to other approaches in the field of targeted protein degradation. Here we disclose 16 novel stabilisers of the 14-3-3/SLP76 PPI across multiple different chemotypes. Based on the early results presented here we would recommend this approach to find molecular glues with broad applicability in the field of 14-3-3 PPIs. The stabilisation of protein-protein interactions (PPIs) through molecular glues is a novel and promising approach in drug discovery.
AbstractList The stabilisation of protein-protein interactions (PPIs) through molecular glues is a novel and promising approach in drug discovery. In stark contrast to research in protein-protein inhibition the field of stabilisation remains underdeveloped with comparatively few examples of small-molecule stabilisers of PPIs reported to date. At the same time identifying molecular glues has received recent sustained interest, especially in the fields of targeted protein degradation and 14-3-3 PPIs. The hub-protein 14-3-3 has a broad interactome with more than 500 known protein partners which presents a great opportunity for therapeutic intervention. In this study we have developed an HTRF assay suitable for HTS of the 14-3-3/SLP76 PPI and have completed a proof of concept screen against a chemically diverse library of 20 K molecules. The adaptor protein SLP76 has been reported to interact with 14-3-3 proteins downstream of the TCR playing an important role in mediating its own proteasomal degradation. We believe that stabilisation of this PPI could be exploited to potentiate degradation of SLP76 and therefore inhibit TCR signalling. This would represent an interesting alternative to other approaches in the field of targeted protein degradation. Here we disclose 16 novel stabilisers of the 14-3-3/SLP76 PPI across multiple different chemotypes. Based on the early results presented here we would recommend this approach to find molecular glues with broad applicability in the field of 14-3-3 PPIs. The stabilisation of protein-protein interactions (PPIs) through molecular glues is a novel and promising approach in drug discovery.
The stabilisation of protein-protein interactions (PPIs) through molecular glues is a novel and promising approach in drug discovery. In stark contrast to research in protein-protein inhibition the field of stabilisation remains underdeveloped with comparatively few examples of small-molecule stabilisers of PPIs reported to date. At the same time identifying molecular glues has received recent sustained interest, especially in the fields of targeted protein degradation and 14-3-3 PPIs. The hub-protein 14-3-3 has a broad interactome with more than 500 known protein partners which presents a great opportunity for therapeutic intervention. In this study we have developed an HTRF assay suitable for HTS of the 14-3-3/SLP76 PPI and have completed a proof of concept screen against a chemically diverse library of 20 K molecules. The adaptor protein SLP76 has been reported to interact with 14-3-3 proteins downstream of the TCR playing an important role in mediating its own proteasomal degradation. We believe that stabilisation of this PPI could be exploited to potentiate degradation of SLP76 and therefore inhibit TCR signalling. This would represent an interesting alternative to other approaches in the field of targeted protein degradation. Here we disclose 16 novel stabilisers of the 14-3-3/SLP76 PPI across multiple different chemotypes. Based on the early results presented here we would recommend this approach to find molecular glues with broad applicability in the field of 14-3-3 PPIs.The stabilisation of protein-protein interactions (PPIs) through molecular glues is a novel and promising approach in drug discovery. In stark contrast to research in protein-protein inhibition the field of stabilisation remains underdeveloped with comparatively few examples of small-molecule stabilisers of PPIs reported to date. At the same time identifying molecular glues has received recent sustained interest, especially in the fields of targeted protein degradation and 14-3-3 PPIs. The hub-protein 14-3-3 has a broad interactome with more than 500 known protein partners which presents a great opportunity for therapeutic intervention. In this study we have developed an HTRF assay suitable for HTS of the 14-3-3/SLP76 PPI and have completed a proof of concept screen against a chemically diverse library of 20 K molecules. The adaptor protein SLP76 has been reported to interact with 14-3-3 proteins downstream of the TCR playing an important role in mediating its own proteasomal degradation. We believe that stabilisation of this PPI could be exploited to potentiate degradation of SLP76 and therefore inhibit TCR signalling. This would represent an interesting alternative to other approaches in the field of targeted protein degradation. Here we disclose 16 novel stabilisers of the 14-3-3/SLP76 PPI across multiple different chemotypes. Based on the early results presented here we would recommend this approach to find molecular glues with broad applicability in the field of 14-3-3 PPIs.
The stabilisation of protein–protein interactions (PPIs) through molecular glues is a novel and promising approach in drug discovery. In stark contrast to research in protein–protein inhibition the field of stabilisation remains underdeveloped with comparatively few examples of small-molecule stabilisers of PPIs reported to date. At the same time identifying molecular glues has received recent sustained interest, especially in the fields of targeted protein degradation and 14-3-3 PPIs. The hub-protein 14-3-3 has a broad interactome with more than 500 known protein partners which presents a great opportunity for therapeutic intervention. In this study we have developed an HTRF assay suitable for HTS of the 14-3-3/SLP76 PPI and have completed a proof of concept screen against a chemically diverse library of 20 K molecules. The adaptor protein SLP76 has been reported to interact with 14-3-3 proteins downstream of the TCR playing an important role in mediating its own proteasomal degradation. We believe that stabilisation of this PPI could be exploited to potentiate degradation of SLP76 and therefore inhibit TCR signalling. This would represent an interesting alternative to other approaches in the field of targeted protein degradation. Here we disclose 16 novel stabilisers of the 14-3-3/SLP76 PPI across multiple different chemotypes. Based on the early results presented here we would recommend this approach to find molecular glues with broad applicability in the field of 14-3-3 PPIs. The stabilisation of protein–protein interactions (PPIs) through molecular glues is a novel and promising approach in drug discovery.
The stabilisation of protein–protein interactions (PPIs) through molecular glues is a novel and promising approach in drug discovery. In stark contrast to research in protein–protein inhibition the field of stabilisation remains underdeveloped with comparatively few examples of small-molecule stabilisers of PPIs reported to date. At the same time identifying molecular glues has received recent sustained interest, especially in the fields of targeted protein degradation and 14-3-3 PPIs. The hub-protein 14-3-3 has a broad interactome with more than 500 known protein partners which presents a great opportunity for therapeutic intervention. In this study we have developed an HTRF assay suitable for HTS of the 14-3-3/SLP76 PPI and have completed a proof of concept screen against a chemically diverse library of 20 K molecules. The adaptor protein SLP76 has been reported to interact with 14-3-3 proteins downstream of the TCR playing an important role in mediating its own proteasomal degradation. We believe that stabilisation of this PPI could be exploited to potentiate degradation of SLP76 and therefore inhibit TCR signalling. This would represent an interesting alternative to other approaches in the field of targeted protein degradation. Here we disclose 16 novel stabilisers of the 14-3-3/SLP76 PPI across multiple different chemotypes. Based on the early results presented here we would recommend this approach to find molecular glues with broad applicability in the field of 14-3-3 PPIs.
Author Redhead, Martin
Leysen, Seppe
Ottmann, Christian
Soini, Lorenzo
Davis, Jeremy
Westwood, Marta
AuthorAffiliation Department of Structural Biology and Biophysics
Structural Biology
Chesterford Research Park
Department of Biomedical Engineering and Institute for Complex Molecular Systems
Discovery
Laboratory of Chemical Biology
Exscientia Ltd
Eindhoven University of Technology
UCB Celltech
Department of Chemistry
Oxford Science Park
Charles River
Schrodinger Building
AuthorAffiliation_xml – name: UCB Celltech
– name: Department of Chemistry
– name: Charles River
– name: Discovery
– name: Schrodinger Building
– name: Department of Structural Biology and Biophysics
– name: Department of Biomedical Engineering and Institute for Complex Molecular Systems
– name: Chesterford Research Park
– name: Structural Biology
– name: Laboratory of Chemical Biology
– name: Exscientia Ltd
– name: Oxford Science Park
– name: Eindhoven University of Technology
Author_xml – sequence: 1
  givenname: Lorenzo
  surname: Soini
  fullname: Soini, Lorenzo
– sequence: 2
  givenname: Martin
  surname: Redhead
  fullname: Redhead, Martin
– sequence: 3
  givenname: Marta
  surname: Westwood
  fullname: Westwood, Marta
– sequence: 4
  givenname: Seppe
  surname: Leysen
  fullname: Leysen, Seppe
– sequence: 5
  givenname: Jeremy
  surname: Davis
  fullname: Davis, Jeremy
– sequence: 6
  givenname: Christian
  surname: Ottmann
  fullname: Ottmann, Christian
BookMark eNptkUtLAzEUhYNUbK3duBdmKcLYPOaRbARp1RYqKuo6pJmkjcxMapIR_PdOH9QHru7l5twvOTnHoFPbWgFwiuAlgoQNC1QVEKIcLw9AD2cExzSjuPOj74KB928QQpwilKXsCHRJkmU5S1EPPE0LVQejjRTB2DqyOqpsqWRTChctykb59SgsVfQ8e8yzIUpiEpNo5WxQpo53NTJ1UE7INeIEHGpRejXY1T54vb15GU3i2cPddHQ9i2UC0xBLgrSYa6xYkSuGMUU00QhKkhPBEIXzghGRa8U0EYnCRGjIaNYaoIWEidSkD6623FUzr1QhWxtOlHzlTCXcJ7fC8N8ntVnyhf3gNEkZwXkLON8BnH1vjQZeGS9VWYpa2cZznNIEIpwS2EovtlLprPdO6f01CPJ1DHyM7sebGCatGP4RSxM2v9s-w5T_r5xtV5yXe_R3suQLrg6UKg
CitedBy_id crossref_primary_10_1002_advs_202508543
crossref_primary_10_1080_13543776_2024_2378076
crossref_primary_10_1016_j_bpj_2022_02_025
crossref_primary_10_1021_acs_accounts_5c00441
crossref_primary_10_1016_j_cbpa_2022_102169
crossref_primary_10_1016_j_molcel_2023_02_018
crossref_primary_10_1016_j_chembiol_2024_04_002
Cites_doi 10.1021/jacs.8b11658
10.1016/j.ejmech.2020.112539
10.1038/srep31988
10.1038/nri1750
10.1016/j.pbiomolbio.2015.05.002
10.1021/ja209924v
10.1158/0008-5472.CAN-07-3177
10.1073/pnas.1312701111
10.1038/s41392-020-00315-3
10.1016/0092-8674(92)90158-9
10.1021/bi991353h
10.1016/j.cell.2020.12.020
10.1111/j.1476-5381.1960.tb01217.x
10.1016/0092-8674(91)90124-H
10.1093/hmg/ddw270
10.1002/anie.202008585
10.1016/j.ddtec.2019.01.001
10.1074/jbc.M112.371062
10.1038/s41589-020-0647-1
10.1042/EBC20170041
10.1002/chem.202001608
10.1016/j.jmb.2009.01.005
10.1002/1873-3468.13993
10.1038/203297a0
10.1126/science.1177319
10.1021/acs.jmedchem.9b01942
10.1084/jem.20062066
10.1016/j.yexcr.2007.07.028
10.1021/cb4003464
10.1016/0014-5793(94)00949-X
10.1073/pnas.1516631113
10.1073/pnas.0608426104
10.1039/C9MD00263D
10.1016/j.pharmthera.2017.02.027
10.1039/C9MD00215D
10.1091/mbc.e11-08-0662
10.1016/j.bmcl.2008.07.114
10.1021/acs.jmedchem.6b00735
10.1038/nmeth.2519
10.1152/physrev.00027.2001
10.1016/j.semcdb.2011.09.012
10.1016/j.semcdb.2011.09.001
10.1182/blood-2015-07-567958
10.1016/S0092-8674(00)80487-0
10.1016/j.chembiol.2014.09.001
10.1002/anie.200907203
10.1038/ni1416
10.1007/978-1-4419-6676-6_16
10.1074/mcp.M110.005751
10.1016/j.molcel.2006.12.017
10.1002/anie.200603853
10.1038/s12276-018-0097-y
10.1146/annurev.immunol.20.092601.111357
10.1074/jbc.273.26.16305
10.3389/fnmol.2017.00318
10.1016/j.ddtec.2017.11.008
10.1016/j.semcancer.2006.03.005
10.1021/jacs.1c03035
10.1074/jbc.M111.310946
10.1021/cb300599t
10.1016/j.bmcl.2018.04.046
10.1111/j.1471-4159.2008.05716.x
10.1016/j.semcancer.2006.03.002
10.1038/leu.2012.119
10.1042/BJ20100784
ContentType Journal Article
Copyright This journal is © The Royal Society of Chemistry.
This journal is © The Royal Society of Chemistry 2021 RSC
Copyright_xml – notice: This journal is © The Royal Society of Chemistry.
– notice: This journal is © The Royal Society of Chemistry 2021 RSC
DBID AAYXX
CITATION
7X8
5PM
DOI 10.1039/d1md00172h
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
Chemistry
EISSN 2632-8682
EndPage 1564
ExternalDocumentID PMC8459327
10_1039_D1MD00172H
d1md00172h
GrantInformation_xml – fundername: ;
  grantid: 675179
GroupedDBID 53G
AAJAE
AANOJ
ABASK
ABDVN
ABRYZ
AGRSR
ALMA_UNASSIGNED_HOLDINGS
ANUXI
BLAPV
C6K
CKLOX
ECGLT
RCNCU
AAFBY
AAXHV
AAYXX
ABJNI
ABPDG
AENGV
AETIL
AFOGI
AFRZK
AGEGJ
AGMRB
AKMSF
CITATION
EBS
H13
M~E
RAOCF
RPM
7X8
5PM
ID FETCH-LOGICAL-c405t-c31fabf2e9d7e9228184f10c373a9180bd93a7fe9f3a4e23af09861168dc04cf3
ISICitedReferencesCount 11
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000680096600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2632-8682
IngestDate Tue Nov 04 01:55:35 EST 2025
Sun Nov 09 10:11:47 EST 2025
Tue Nov 18 22:12:09 EST 2025
Sat Nov 29 02:58:10 EST 2025
Mon May 02 04:31:11 EDT 2022
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c405t-c31fabf2e9d7e9228184f10c373a9180bd93a7fe9f3a4e23af09861168dc04cf3
Notes 10.1039/d1md00172h
Electronic supplementary information (ESI) available. See DOI
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-7315-0315
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8459327
PMID 34667951
PQID 2584012530
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8459327
crossref_citationtrail_10_1039_D1MD00172H
crossref_primary_10_1039_D1MD00172H
proquest_miscellaneous_2584012530
rsc_primary_d1md00172h
PublicationCentury 2000
PublicationDate 20210923
PublicationDateYYYYMMDD 2021-09-23
PublicationDate_xml – month: 9
  year: 2021
  text: 20210923
  day: 23
PublicationDecade 2020
PublicationTitle RSC medicinal chemistry
PublicationYear 2021
Publisher RSC
Publisher_xml – name: RSC
References Nguyen (D1MD00172H/cit25) 2018; 50
Schreiber (D1MD00172H/cit5) 2021; 184
Schneekloth (D1MD00172H/cit10) 2008; 18
Glickman (D1MD00172H/cit22) 2002; 82
Sadik (D1MD00172H/cit41) 2009; 108
Wang (D1MD00172H/cit28) 2012; 287
Hughes (D1MD00172H/cit21) 2017; 61
Ottmann (D1MD00172H/cit47) 2009; 386
Guillory (D1MD00172H/cit55) 2020; 63
Oecking (D1MD00172H/cit45) 1994; 352
Samelson (D1MD00172H/cit61) 2002; 20
Soini (D1MD00172H/cit63) 2020; 595
Feng (D1MD00172H/cit19) 2020; 16
Lopez-Girona (D1MD00172H/cit14) 2012; 26
Aitken (D1MD00172H/cit33) 2006; 16
Schreiber (D1MD00172H/cit6) 1992; 70
Miteva (D1MD00172H/cit26) 2010; 54
Johnson (D1MD00172H/cit35) 2011; 10
Neklesa (D1MD00172H/cit8) 2017; 174
Liu (D1MD00172H/cit7) 1991; 66
Lu (D1MD00172H/cit3) 2020; 5
Milroy (D1MD00172H/cit49) 2013; 8
Ottmann (D1MD00172H/cit4) 2017; 24
Yamada (D1MD00172H/cit24) 2016; 6
Williams (D1MD00172H/cit50) 2007; 46
Shui (D1MD00172H/cit59) 2007; 8
Bier (D1MD00172H/cit1) 2015; 119
Zhang (D1MD00172H/cit17) 2019; 31
Wolter (D1MD00172H/cit56) 2020; 59
Danes (D1MD00172H/cit38) 2008; 68
Cossar (D1MD00172H/cit57) 2021; 143
Wang (D1MD00172H/cit64) 1999; 38
Ito (D1MD00172H/cit15) 2010; 327
Wang (D1MD00172H/cit27) 2012; 287
Fink (D1MD00172H/cit13) 2015; 126
Buckley (D1MD00172H/cit11) 2012; 134
Obsil (D1MD00172H/cit34) 2011; 22
Valeur (D1MD00172H/cit18) 2019; 10
Dzamko (D1MD00172H/cit40) 2010; 430
Hermeking (D1MD00172H/cit36) 2006; 16
Swaney (D1MD00172H/cit23) 2013; 10
Sijbesma (D1MD00172H/cit54) 2019; 141
Arkin (D1MD00172H/cit2) 2014; 21
Molzan (D1MD00172H/cit46) 2013; 8
Cornell (D1MD00172H/cit30) 2016; 25
Zhao (D1MD00172H/cit37) 2011; 22
Toyomasu (D1MD00172H/cit51) 2007; 104
Che (D1MD00172H/cit20) 2018; 28
Somers (D1MD00172H/cit12) 1960; 15
Yaffe (D1MD00172H/cit32) 1997; 91
Ballio (D1MD00172H/cit44) 1964; 203
Valenti (D1MD00172H/cit58) 2019; 10
Muda (D1MD00172H/cit39) 2013; 111
Rose (D1MD00172H/cit52) 2010; 49
Bosica (D1MD00172H/cit53) 2020; 26
Stevers (D1MD00172H/cit42) 2016; 113
Liang (D1MD00172H/cit43) 2012; 23
Koretzky (D1MD00172H/cit62) 2006; 6
Mizuno (D1MD00172H/cit29) 2007; 313
Cornell (D1MD00172H/cit31) 2017; 10
Crews (D1MD00172H/cit16) 2016; 59
Petosa (D1MD00172H/cit65) 1998; 273
Zhou (D1MD00172H/cit9) 2020; 203
Ottmann (D1MD00172H/cit48) 2007; 25
Di Bartolo (D1MD00172H/cit60) 2007; 204
References_xml – volume: 141
  start-page: 3524
  year: 2019
  ident: D1MD00172H/cit54
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.8b11658
– volume: 203
  start-page: 112539
  year: 2020
  ident: D1MD00172H/cit9
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2020.112539
– volume: 6
  start-page: 31988
  year: 2016
  ident: D1MD00172H/cit24
  publication-title: Sci. Rep.
  doi: 10.1038/srep31988
– volume: 6
  start-page: 67
  year: 2006
  ident: D1MD00172H/cit62
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri1750
– volume: 119
  start-page: 10
  year: 2015
  ident: D1MD00172H/cit1
  publication-title: Prog. Biophys. Mol. Biol.
  doi: 10.1016/j.pbiomolbio.2015.05.002
– volume: 134
  start-page: 4465
  year: 2012
  ident: D1MD00172H/cit11
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja209924v
– volume: 68
  start-page: 1760
  year: 2008
  ident: D1MD00172H/cit38
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-3177
– volume: 111
  start-page: E34
  year: 2013
  ident: D1MD00172H/cit39
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1312701111
– volume: 5
  start-page: 213
  year: 2020
  ident: D1MD00172H/cit3
  publication-title: Signal Transduction Targeted Ther.
  doi: 10.1038/s41392-020-00315-3
– volume: 70
  start-page: 365
  year: 1992
  ident: D1MD00172H/cit6
  publication-title: Cell
  doi: 10.1016/0092-8674(92)90158-9
– volume: 38
  start-page: 12499
  year: 1999
  ident: D1MD00172H/cit64
  publication-title: Biochemistry
  doi: 10.1021/bi991353h
– volume: 184
  start-page: 3
  year: 2021
  ident: D1MD00172H/cit5
  publication-title: Cell
  doi: 10.1016/j.cell.2020.12.020
– volume: 15
  start-page: 111
  year: 1960
  ident: D1MD00172H/cit12
  publication-title: Br. J. Pharmacol. Chemother.
  doi: 10.1111/j.1476-5381.1960.tb01217.x
– volume: 66
  start-page: 807
  year: 1991
  ident: D1MD00172H/cit7
  publication-title: Cell
  doi: 10.1016/0092-8674(91)90124-H
– volume: 25
  start-page: 4405
  year: 2016
  ident: D1MD00172H/cit30
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddw270
– volume: 59
  start-page: 21520
  issue: 48
  year: 2020
  ident: D1MD00172H/cit56
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.202008585
– volume: 31
  start-page: 53
  year: 2019
  ident: D1MD00172H/cit17
  publication-title: Drug Discovery Today: Technol.
  doi: 10.1016/j.ddtec.2019.01.001
– volume: 287
  start-page: 34091
  year: 2012
  ident: D1MD00172H/cit27
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M112.371062
– volume: 16
  start-page: 1154
  year: 2020
  ident: D1MD00172H/cit19
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/s41589-020-0647-1
– volume: 61
  start-page: 505
  year: 2017
  ident: D1MD00172H/cit21
  publication-title: Essays Biochem.
  doi: 10.1042/EBC20170041
– volume: 26
  start-page: 7131
  year: 2020
  ident: D1MD00172H/cit53
  publication-title: Chemistry
  doi: 10.1002/chem.202001608
– volume: 386
  start-page: 913
  year: 2009
  ident: D1MD00172H/cit47
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2009.01.005
– volume: 595
  start-page: 404
  year: 2020
  ident: D1MD00172H/cit63
  publication-title: FEBS Lett.
  doi: 10.1002/1873-3468.13993
– volume: 203
  start-page: 297
  year: 1964
  ident: D1MD00172H/cit44
  publication-title: Nature
  doi: 10.1038/203297a0
– volume: 327
  start-page: 1345
  year: 2010
  ident: D1MD00172H/cit15
  publication-title: Science
  doi: 10.1126/science.1177319
– volume: 63
  start-page: 6694
  year: 2020
  ident: D1MD00172H/cit55
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.9b01942
– volume: 204
  start-page: 681
  year: 2007
  ident: D1MD00172H/cit60
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20062066
– volume: 313
  start-page: 3624
  year: 2007
  ident: D1MD00172H/cit29
  publication-title: Exp. Cell Res.
  doi: 10.1016/j.yexcr.2007.07.028
– volume: 8
  start-page: 1869
  year: 2013
  ident: D1MD00172H/cit46
  publication-title: ACS Chem. Biol.
  doi: 10.1021/cb4003464
– volume: 352
  start-page: 163
  year: 1994
  ident: D1MD00172H/cit45
  publication-title: FEBS Lett.
  doi: 10.1016/0014-5793(94)00949-X
– volume: 113
  start-page: E1152
  year: 2016
  ident: D1MD00172H/cit42
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1516631113
– volume: 104
  start-page: 3084
  year: 2007
  ident: D1MD00172H/cit51
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0608426104
– volume: 10
  start-page: 1550
  year: 2019
  ident: D1MD00172H/cit18
  publication-title: MedChemComm
  doi: 10.1039/C9MD00263D
– volume: 174
  start-page: 138
  year: 2017
  ident: D1MD00172H/cit8
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2017.02.027
– volume: 10
  start-page: 1796
  year: 2019
  ident: D1MD00172H/cit58
  publication-title: MedChemComm
  doi: 10.1039/C9MD00215D
– volume: 23
  start-page: 996
  year: 2012
  ident: D1MD00172H/cit43
  publication-title: Mol. Biol. Cell
  doi: 10.1091/mbc.e11-08-0662
– volume: 18
  start-page: 5904
  year: 2008
  ident: D1MD00172H/cit10
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2008.07.114
– volume: 59
  start-page: 5129
  year: 2016
  ident: D1MD00172H/cit16
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.6b00735
– volume: 10
  start-page: 676
  year: 2013
  ident: D1MD00172H/cit23
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.2519
– volume: 82
  start-page: 373
  year: 2002
  ident: D1MD00172H/cit22
  publication-title: Physiol. Rev.
  doi: 10.1152/physrev.00027.2001
– volume: 22
  start-page: 705
  year: 2011
  ident: D1MD00172H/cit37
  publication-title: Semin. Cell Dev. Biol.
  doi: 10.1016/j.semcdb.2011.09.012
– volume: 22
  start-page: 663
  year: 2011
  ident: D1MD00172H/cit34
  publication-title: Semin. Cell Dev. Biol.
  doi: 10.1016/j.semcdb.2011.09.001
– volume: 126
  start-page: 2366
  year: 2015
  ident: D1MD00172H/cit13
  publication-title: Blood
  doi: 10.1182/blood-2015-07-567958
– volume: 91
  start-page: 961
  year: 1997
  ident: D1MD00172H/cit32
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80487-0
– volume: 21
  start-page: 1102
  year: 2014
  ident: D1MD00172H/cit2
  publication-title: Chem. Biol.
  doi: 10.1016/j.chembiol.2014.09.001
– volume: 49
  start-page: 4129
  year: 2010
  ident: D1MD00172H/cit52
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.200907203
– volume: 8
  start-page: 84
  year: 2007
  ident: D1MD00172H/cit59
  publication-title: Nat. Immunol.
  doi: 10.1038/ni1416
– volume: 54
  start-page: 195
  year: 2010
  ident: D1MD00172H/cit26
  publication-title: Subcell. Biochem.
  doi: 10.1007/978-1-4419-6676-6_16
– volume: 10
  start-page: M110.005751
  year: 2011
  ident: D1MD00172H/cit35
  publication-title: Mol. Cell. Proteomics
  doi: 10.1074/mcp.M110.005751
– volume: 25
  start-page: 427
  year: 2007
  ident: D1MD00172H/cit48
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2006.12.017
– volume: 46
  start-page: 915
  year: 2007
  ident: D1MD00172H/cit50
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.200603853
– volume: 50
  start-page: 1
  year: 2018
  ident: D1MD00172H/cit25
  publication-title: Exp. Mol. Med.
  doi: 10.1038/s12276-018-0097-y
– volume: 20
  start-page: 371
  year: 2002
  ident: D1MD00172H/cit61
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.20.092601.111357
– volume: 273
  start-page: 16305
  year: 1998
  ident: D1MD00172H/cit65
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.273.26.16305
– volume: 10
  start-page: 318
  year: 2017
  ident: D1MD00172H/cit31
  publication-title: Front. Mol. Neurosci.
  doi: 10.3389/fnmol.2017.00318
– volume: 24
  start-page: 1
  year: 2017
  ident: D1MD00172H/cit4
  publication-title: Drug Discovery Today: Technol.
  doi: 10.1016/j.ddtec.2017.11.008
– volume: 16
  start-page: 162
  year: 2006
  ident: D1MD00172H/cit33
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2006.03.005
– volume: 143
  start-page: 8454
  year: 2021
  ident: D1MD00172H/cit57
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.1c03035
– volume: 287
  start-page: 11037
  year: 2012
  ident: D1MD00172H/cit28
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.310946
– volume: 8
  start-page: 27
  year: 2013
  ident: D1MD00172H/cit49
  publication-title: ACS Chem. Biol.
  doi: 10.1021/cb300599t
– volume: 28
  start-page: 2585
  year: 2018
  ident: D1MD00172H/cit20
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2018.04.046
– volume: 108
  start-page: 33
  year: 2009
  ident: D1MD00172H/cit41
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2008.05716.x
– volume: 16
  start-page: 183
  year: 2006
  ident: D1MD00172H/cit36
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2006.03.002
– volume: 26
  start-page: 2326
  year: 2012
  ident: D1MD00172H/cit14
  publication-title: Leukemia
  doi: 10.1038/leu.2012.119
– volume: 430
  start-page: 405
  year: 2010
  ident: D1MD00172H/cit40
  publication-title: Biochem. J.
  doi: 10.1042/BJ20100784
SSID ssj0002511659
Score 2.3105938
Snippet The stabilisation of protein-protein interactions (PPIs) through molecular glues is a novel and promising approach in drug discovery. In stark contrast to...
The stabilisation of protein–protein interactions (PPIs) through molecular glues is a novel and promising approach in drug discovery. In stark contrast to...
SourceID pubmedcentral
proquest
crossref
rsc
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 1555
SubjectTerms Chemistry
Title Identification of molecular glues of the SLP76/14-3-3 protein-protein interaction
URI https://www.proquest.com/docview/2584012530
https://pubmed.ncbi.nlm.nih.gov/PMC8459327
Volume 12
WOSCitedRecordID wos000680096600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2632-8682
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002511659
  issn: 2632-8682
  databaseCode: M~E
  dateStart: 20200101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwELXYwoELAkHFQqmC4IIq08ROYvuIWlAPbVXYIu0tShybXal1VtldVPXAb2ds57MqEhy4JCvbm0h-k_GMZ_wGofeW1cqSlmCteIJjqTUutGI4pzwuVailLLUrNsHOz_l8Li6aVN61KyfAjOE3N2L1X6GGNgDbHp39B7i7h0ID_AbQ4Qqww_WvgPdHb3WzF-fi520J3IMfV1tPMmvNzdnpBXMudYwppgeOsWFpcHN3RBK1P_YwtGC_zY7agLylFmnrxXU7NdXS-APXVa3MbdUFdFS5aMTJMxf0IaH1ps37sT3dMnEKMuZ14kytVmq4PUEim0vhTxB_VE6NWUJ4zFM-1rlkIFtioEDBvEkGi7GlsrlX0YfU8qSW0XXpvNhFv5x1SYZ95wQ9JCwRVumd_eq34Kx3lSaiJa2l4rD_y9hM6X2Pu5mzk7otFOMMksun6EnjSQSfvAQ8Qw-UeY6-jtEPKh106AcOfdsE6AcO_UOPfXAH-2CA_Qv0_cvny6MT3FTNwBKM7w2WNNJ5oYkSJVOCWLavWEehpIzmIuJhUQqaM62EpnmsCM11KHgKM8FLGcLHSnfRjqmMeokCTXJBwEBn0hLZiaSICzDQY65TVZQyDafoQztJmWwo5W1lk6vMpTZQkR1HZ8duQk-m6F03duWJVO4d9bad6wzE1wavcqOq7TojYCmDMZVQeCsbgdA9zjKlj3vMcuEY03mcgJ_CpmgX4OrG92i_-lPHa_S4F-o9tLOpt-oNeiR_bpbreh9N2JzvO6H6DdSRkLQ
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+molecular+glues+of+the+SLP76%2F14-3-3+protein-protein+interaction&rft.jtitle=RSC+medicinal+chemistry&rft.au=Soini%2C+Lorenzo&rft.au=Redhead%2C+Martin&rft.au=Westwood%2C+Marta&rft.au=Leysen%2C+Seppe&rft.date=2021-09-23&rft.eissn=2632-8682&rft.volume=12&rft.issue=9&rft.spage=1555&rft.epage=1564&rft_id=info:doi/10.1039%2Fd1md00172h&rft.externalDocID=d1md00172h
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2632-8682&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2632-8682&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2632-8682&client=summon